Results 131 to 140 of about 33,599 (301)

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

HYPNOTISM IN SCANDINAVIA [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1890
n ...
openaire   +2 more sources

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Accidental overdose admissions and premature death: A large population‐based data‐linkage cohort study in New South Wales, Australia (PAVLOVA 4)

open access: yesAddiction, EarlyView.
Abstract Background and aims People with substance use disorders have reduced life‐expectancy; however, risks of premature death from injuries and natural causes following an accidental overdose are not well characterised. This study aimed to estimate risk of premature death (by cause and over time), and disease burden following hospitalised accidental
Firouzeh Noghrehchi   +5 more
wiley   +1 more source

Drug use disorders among people convicted of large‐, moderate‐ and small‐scale drug supply crimes: A register‐based retrospective comparative study

open access: yesAddiction, EarlyView.
Abstract Background and aims Heavy drug use has been associated with small‐scale drug crime, but the substance use histories of individuals involved in the manufacturing, smuggling and wholesaling of larger quantities of drugs [here referred to as serious drug crimes (SDC)] have been largely unexamined.
Julie Elizabeth Brummer   +3 more
wiley   +1 more source

Methylenedioxymethamphetamine (MDMA)‐related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology

open access: yesAddiction, EarlyView.
Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke   +5 more
wiley   +1 more source

Sedatives and hypnotics

open access: yes, 2011
Tato práce se zabývá léčivy ze skupiny sedativa a hypnotika s důrazem na jejich chemickou syntézu. Práce také popisuje současný stav v používání jednotlivých látek z této skupiny v klinické praxi v ČR.This work deals with a group of drugs and sedatives ...
Sova, Jaromír
core   +2 more sources

Variation in 90‐day substance use disorder‐related acute care events across United States opioid treatment programs: A Medicaid claims analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Creating and tracking quality measures has improved outcomes in many areas of healthcare; however, quality measures specific to opioid treatment programs (OTPs) have not yet been developed. Based on the success seen in other fields, introducing quality measures in OTPs should help enhance positive outcomes and decrease ...
Barrett Wallace Montgomery   +7 more
wiley   +1 more source

Predicting high‐risk novel benzodiazepines: A surveillance study of novel benzodiazepine detections and a case series of bromazolam exposures in New South Wales, Australia

open access: yesAddiction, EarlyView.
Abstract Background and aims Novel benzodiazepines are increasingly detected in poisonings. Their relative toxicities remain poorly defined, complicating public health responses. Bromazolam has emerged in recent reports of severe poisoning. We sought a method to identify higher‐risk novel benzodiazepines, and to describe the clinical effects of ...
Emily Z. G. Sansoni   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy